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Ltd. This is an open access article undAbstract Objective: To report T1-2N0 tongue cancer recurrences initially treated with sur-
gery alone.
Methods: Between 1990 and 2010, 27 patients at tertiary hospital referral center institution
were treated with curative intent for locoregional recurrence after initial glossectomy with
or without neck dissection for T1-2N0 tongue cancer. None had received adjuvant postopera-
tive radiation as a component of the original treatment.
Results: Median time to locoregional recurrence was 12 months (range 5e39 months) and 78%
of failures occurred in the first 2 years. Most treatment failures were local (63%). Salvage strat-
egy was risk-adapted by individual patient. The 5-year disease specific survival (DSS) was 61%.
Patients with local recurrences alone fared significantly better than those with regional recur-
rences (5-yr DSS: 86% vs. 22%, PZ 0.0018). Local recurrences were usually treated by surgery
alone, while regional recurrences were more commonly treated with combined modality treat-
ment (P Z 0.005).ican Radium Society, April 27-May 1, 2014. St Thomas.
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World Journal of OtorhinolaryngologConclusions: Recurrence of early stage oral tongue cancer can be successfully salvaged in a
majority of cases. Patients developing regional recurrence have significantly worse prognosis
than those with local failures.
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Primary surgery is the standard of care for early stage (T1-
2N0-1) squamous cell carcinoma of the oral tongue.1,2 The
clinically and/or radiographically N0 neck is managed ac-
cording to tumor thickness: patients with thin tumors are
observed, while elective neck dissection is performed for
thick tumors.3e5 Post-operatively, patients with risk factors
for local-regional recurrence are recommended adjuvant
radiation while those without are observed.6 The results of
this management technique are effective for both Stage I/II
oral tongue tumors managed either with surgery alone7 or
combined modality therapy.8
Since local and regional recurrences of early oral tongue
cancers are uncommon and the local recurrences are
unique, management of recurrent disease is individualized.
The treatment of a tongue cancer relapse is influenced by
management of the original tumor. Whether the neck was
dissected or observed, the administration of adjuvant ra-
diation, the local extent of the local or regional disease,
and the duration between initial treatment and diagnosis of
recurrence may all affect management decisions. Thus, a
detailed analysis of the salvage early oral tongue cancer
failures needs a detailed analysis of the prior oral tongue
cancer management.
This series examines a single institution experience with
attempted salvage for isolated local-regional oral tongue
cancer recurrences after initial management with surgery
alone.Materials and methods
We retrospectively identified all patients with early stage
squamous cell carcinoma of the oral tongue who were
treated with primary surgical resection alone from 1990 to
2010 at Fox Chase Cancer Center. Inclusion criteria were
American Joint Committee and Cancer (AJCC) Stage IeII T1-
2N0 squamous cell carcinoma of the oral tongue with
definitive surgical resection performed at a single institu-
tion. The decision to perform glossectomy versus glossec-
tomy/neck dissection in initial management was
determined by the treating surgeon.
Patients who received post-operative radiation, had
involved neck lymph nodes on pathology that were not
clinically evident, and patients with involved surgical
margins were considered representative of a higher risk
population and were excluded from this analysis. Patient
demographics, tumor characteristics, and treatment
related outcomes were abstracted from the relevant
medical records in accordance with a Fox Chase Cancer
Center Institutional Review Board approved protocol and
the Health Insurance Portability and Accountability Act.JC, et al., Early oral tongue canc
y-Head and Neck Surgery (2016),All patients underwent glossectomy for definitive man-
agement of their presenting tongue cancer diagnosis. Pa-
tients presenting from an outside institution after a
diagnostic excisional biopsy were submitted to additional
wide local resection/glossectomy to confirm adequacy of
resection of the lesion.
After the initial operation, patients were followed in
clinic according to standard practice.9 Recurrences of
squamous cancer in the tongue/floor of the mouth or neck
within 5 years of the initial operation were considered re-
currences. Local recurrence was defined as an oral cavity
recurrence at the primary oral cavity site; regional recur-
rence was defined as a recurrence within the neck. Patients
diagnosed with a second primary cancer of the upper aer-
odigestive tract during followup were excluded. Upon
appreciation of local-regional recurrence, biopsy and
staging studies were pursued. Patients with synchronous
distant metastasis were excluded. Treatment of the
recurrence was recommended following discussion at a
multidisciplinary tumor board; in general salvage resection
followed by risk adapted adjuvant radiation was favored. In
the salvage operations for isolated local recurrence, ipsi-
lateral neck node basins that had been managed expec-
tantly at the initial presentation were electively dissected
while those that were electively dissected at the primary
presentation were observed. Isolated regional recurrence
was treated with therapeutic node dissection followed by
risk adapted adjuvant radiation.
Stata (College Station, TX) was used to perform statis-
tical analysis. Univariate analysis was performed by logistic
regression, and multivariate analysis was performed using a
Cox proportional hazards model. Fisher’s exact test was
applied for 2  2 comparisons. Kaplan Meier curves and
tables were also constructed to analyze outcomes.Results
A total of 27 patients developed isolated locoregional
recurrence. Most of the recurrences were from tumors that
were originally T1N0 (81%) and 59% of the overall cohort
was initially managed with glossectomy alone. The median
interval to locoregional relapse was 12.4 months (range
5e39 months) and almost 78% of recurrences occurred in
the first 2 years, with 44% recurring within the first year.
There were no synchronous recurrences in both the tongue
and neck (Table 1). Two patients had perineural invasion on
final pathology but declined radiation therapy.
The majority of locoregional recurrences were confined
to the tongue (n Z 17, 63%) and a majority were managed
with surgery (nZ 20, 75%) followed by risk adapted therapy.
Most node-negative recurrences were rT1-2 (85%) and all of
these local recurrences were addressed by primary surgery.er initially managed with surgery alone: Treatment of recurrence,
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Table 1 Patient demographics and treatment.
Local
recurrence
(n Z 17%)
Regional
recurrence
(n Z 10%)
All patients
(n Z 27%)
P value
Age at diagnosis (yr)
<50 6 (35) 2 (20) 8 (30) P Z 0.67
>50 11 (65) 8 (80) 19 (70)
Average (yr) 56.3 65.9 60.0
Median (yr) 55.1 72.2 61.0
Sex
Male 9 (53) 7 (70) 16 (59) P Z 0.45
Female 8 (47) 3 (30) 11 (41)
Smoking status
Yes 11 (65) 6 (60) 17 (63) P Z 0.69
No 5 (29) 4 (40) 9 (33)
Unknown 1 (6) e 1 (4)
Initial tumor T stage
T1 14 (82) 8 (80) 22 (81) P Z 1.00
T2 3 (18) 2 (20) 5 (19)
Initial treatment
Glossectomy
alone
8 (47) 8 (80) 16 (59) P Z 0.12
Glossectomy
with neck
dissection
9 (53) 2 (20) 11 (41)
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practice for the de novo presentation of oral tongue cancer.
Tumor recurrence alone was not considered an indepen-
dent indication for adjuvant radiation. Slightly more than
half of the patients were treated with adjuvant therapy e
radiation (45%) and chemoradiation (10%). Three patients,
all with local failures, refused any therapy and were
excluded from the survival analysis (Table 2).
All regional recurrences had high risk features and were
recommended combined modality therapy. Most regional
recurrences ensued in a neck that was originally managed
expectantly (n Z 8, 80%); all were ipsilateral. One patient
refused adjuvant radiation and was thus managed with
neck dissection alone for a regional recurrence. That pa-
tient developed disease in the operated neck and suc-
cumbed to recurrent cancer.
Four patients declined surgical salvage and were treated
with either radiation alone or by chemoradiation; half of
these patients achieved disease control at last followup.
The 2-year and 5-year overall survival (OS) for the cohort
was 83% and 50%. The 2-year and 5-year disease specific
survival (DSS) for the cohort was 87% and 61%. Gender and
age were significant (PZ 0.05, PZ 0.015 respectively) for
OS they were not significant on DSS. The median follow-upTable 2 Salvage therapy following local or regional recurrence
Surgery
alone
Radiation
alone
Surgery þ Radiation Ch
Local recurrence 8 2 3 1
Regional recurrence 1 0 6 1
Total 9 2 9 2
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second progression was 18 months (3e39 months).
Multiple factors associated with both the original pre-
sentation of oral tongue cancer and the recurrence were
evaluated for DSS. Tobacco use, initial T-stage, interval
between initial cancer treatment and recurrence, and neck
dissection as part initial treatment were all not significant
for DSS (data not shown). The single significant prognostic
factor was the type of recurrence, local vs. regional, in
both univariate and multivariate analysis (Table 3). The 5
year DSS stratified by site of recurrence was 86% for local
versus 22% regional (PZ 0.0018) (Fig. 1). A majority of local
recurrences (57%) were managed with surgery alone and a
majority of patients with a localized rT1T2N0recurrence
(n Z 12, 71%) survived their disease. Survival following
regional recurrence was poor, regardless of whether the
patient was initially treated with surgery or observation of
the neck (0% and 38%, respectively).
Discussion
Surgery is the recommended treatment strategy for most
early stage tongue cancer.9 Although initial treatment with
an operationis often successful, isolated locoregional re-
currences constitute management problems.10 This analysis
reports the results from treatment of 27 patients initially
treated with surgery alone at a single tertiary referral
center who developed locoregional recurrence. Similar to
other analyses, 80% of these recurrences occurred in the
first 2 years. The reported overall survival after locore-
gional recurrence in such patients is approximately 20%e
50%.10e12 Our 60% DSS salvage survival is slightly higher than
the reported literature. This is possibly due to the high
percentage of rT1T2N0 patients in our series.11
The difference between a local and regional recurrence
is substantial. Local recurrences in this series had a 5-year
DSS of 86% and the local recurrences who could be managed
by surgery alone (57% of all failures) represented a favor-
able subgroup. By contrast, only 22% of patients with
regional metastasis could be salvaged, despite multi-
modality therapy. Although the historical reports of recur-
rent oral tongue cancer suggest that DSS is poor,13 isolated
T1-2 local recurrence can be managed successfully with
single modality therapy. This supports the need for timely
surveillance, especially following the first two years after
resection. Routine adjuvant radiation in the salvage plan
for locoregional recurrence is not supported for local
favorable recurrences.
This analysis is not designed to define the benefits of
staging neck dissection by comparison to an expectant
approach in the initial management early stage oral cancer.
The literature has reported on this question.5,14 In this.
emo-radiation Surgery þ Chemoradiation No
treatment
Total
0 3 17
2 0 10
2 3 27
er initially managed with surgery alone: Treatment of recurrence,
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Fig. 1 KaplaneMeier survival plot of disease specific survival
and recurrence type.
Table 3 Univariate and Multivariate analysis for disease
specific survival.
Unadjusted hazard
ratio (95% CI )
Adjusted hazard
ratio (95% CI )
Under age 60 0.25 (0.05e1.19) 0.41 (0.08e2.17)
Male gender 0.44 (0.18e2.50) 0.90 (0.21e3.96)
Local vs.
regional disease
8.50 (1.74e42.10) 6.70 (1.30e34.40)
The significance values are in bold.
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that was originally approached expectantly. The recom-
mendation for an elective neck dissection in patients with
thin and intermediate thickness lesions is complex. Thicker
tongue lesions, especially those measuring more than 4 mm
are at higher risk for locoregional metastasis and typically
receive elective neck dissection.15 Primary tumor features
like perineural invasion16 and high risk pathological islands
of tongue invasion17 are more likely to undergo initial neck
dissection, although sometimes these factors are not
appreciated until final surgical pathology is available. A
prospective study to determine whether elective neck ra-
diation would adequately control regional nodal disease
closed early due to unacceptable regional progression.18
The best strategy for considering a staging neck dissection
vs. Observation for cT1-2N0 tongue cancer remains to be
defined. Regardless of whether patients undergo neck
dissection in initial management, the type of locoregional
recurrence is the primary driver of outcome following
locoregional recurrence of T1T2N0 oral cavity cancer.Conclusion
Locoregional recurrence following treatment of Stage IeII
tongue cancer by surgery alone poses a treatmentPlease cite this article in press as: Liu JC, et al., Early oral tongue canc
World Journal of Otorhinolaryngology-Head and Neck Surgery (2016),challenge. With appropriate risk-adapted therapy approxi-
mately 60% of patients will survive the disease. Local re-
currences are significantly easier to salvage than regional
recurrences, arguing for the value of careful close surveil-
lance. Regional recurrences have poor outcomes despite
multi-modality therapy.Conflict of interest
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